Private Equity Solutions

Private Equity Fund Of Funds By Dave Porter - Senior Staff Repoter

FF&P Private Equity provides its clients with the opportunity to invest in the equity of high growth, unquoted companies whose objective is to generate attractive returns through the subsequent listing, or trade sale, of these companies. FF&P Private Equity invests typically â5 million to â25 million of equity per transaction and places particular emphasis on backing commercial managers with a track record in successful execution of business plans and enhancing shareholder value. //www.ffandp. equity.

Curve Equity Exposed Fund SCOLR, Inc. listed its common stock on the American Stock Exchange under the ticker symbol DDD. Trading began Friday.

Viridian, the holding company for Northern Ireland's electricity, is in talks over a .62billion bid by Bahraini private equity firm Arcapita Bank.

Equity Income Funds Visit our AXcess News Forum and add your comments on this story. Try your hand at writing, the best story will be published on our news network. Take our health poll too!

Capital Casebook Equity Print This Page

Peter is also Chairman of British International (a helicopter company) Executive Director of Ingenious Media PLC. Amir Eilon, Executive Director Amir Eilon, Executive Director at easyJet, during which time he undertook a key role in the airline’s acquisition of Go and the securing of an option to acquire Deutsche BA. With a wealth of experience in investment banking, Amir’s finance experience includes time at CSFB Private Equity, where he was jointly responsible for a US$600m private equity fund, BZW, where he was Head of Global Capital Markets and Morgan Stanley, where he was responsible for International Equity Markets. Executive Director of MK Airlines, a cargo airline, the Chairman of Spring plc, a LSE listed company, and a NED of Globus, an AIM listed company.

Private Investment In Public February 6, 2004 (AXcess News) Redmond WA - Biopharmaceutical company, SCOLR, Inc. (AMEX: DDD) was approved for trading on the American Stock Exchange Friday, Feb. 6.

from a step by step tutorial to function lists, sample code, common errors and solutions, and much more! 101 pages.

Equity Mutual Funds John McGonegal, senior vice president of the Amex Equities Group said in an announcement Friday, "We look forward to working with SCOLR in building increased investor awareness and visibility within the investment community."

Birmingham Contact Equity Daniel O. Wilds, President and CEO of SCOLR, said, "With the move from the over-the-counter bulletin board to this major national exchange, the Company has the opportunity to attract a broader investor base and to attract institutional investment interest."SCOLR, Inc. had previously traded on the OTC Bulletin Board under the symbol SCLL. Redmond-based SCOLR Inc., formerly known as Nutraceutix Inc., it had sold the last of its agricultural business assets to Lallemand Animal Nutrition of North America of Milwaukee, Wis., a subsidiary of Lallemand Inc. of Montreal, Quebec in February 2003.

Private Equity Investment Firm SCLOR has focused since then on developing supplements for human intestinal health, known as probiotics; and drug delivery systems for any number of health issues. The company said it has devised a delivery system for its probiotics supplements, which allows the company to deliver the product in pill form.

Complying Deal Equity Funds That system, patented as Controlled Delivery Technology platform, could make the delivery of drugs of other types more efficient. For example, if a person needs to take three pills per day under a certain drug regimen, the SCLOR system might be able to reduce that number to one pill per day by regulating the rate at which the body absorbs the drug.

Equity Msn Private Wyoming The Company said that on Dec. 12 a national retailer had placed its first order for two new products using the system in 12-hour formulations of Niacin and EsterC. SCOLR did not identify the retailer, which plans to sell the pills under its own private label.

American Equity Investment In January SCOLR announced that it had agreed to sell one of its two divisions for about $2.72 million.Steven Moger, the chief financial officer and general manager of the division, agreed to buy it.SCOLR said it has planned on the sale of the division for some time, though it has historically generated most of the company's revenues.

Equity Index Funds The division being sold makes dietary supplement pills for the maintenance of human intestinal health.Terms of the deal call for Moger to resign his position as an officer of SCOLR and pay $720,000 in cash at the time the deal closes. The new company would make deferred payments of at least $2 million more, and additional amounts are tied to sales levels and royalties.

Equity Private Team Wyoming Moger's company has been granted the right to use SCOLR's CDT technology in the manufacture of certain products, the company said.

Equity Group Investment No information was available as to Moger's future plans for his new company in regards to becoming a publicly traded company through reverse merger or IPO.While SCOLR sought liquidity through AMEX listing, trading was well received by investors Friday, pushing AMEX: DDD shares up 23 cents, or 7.49 percent, to close at $3.30 on volume of 63,500 shares. The 90-day average daily volume was reported to be $0.82 to $3.70.The specialist assigned by the AMEX in SCOLR, Inc. is Cohen Specialists L.L.C.

Capital Development Equity AXcess News will be reporting on any new market trends related to this story. Members should watch their in-box for late breaking news. If you're not a member, consider joining now. Members get the latest business news, commentaries and stock picks delivered right to their in-box.

[ Comment, Edit or Article Submission ]